GDM is generally a state of both enhanced beta-cell function and marked insulin resistance mediated primarily by placental secretion of diabetogenic hormones, including human placental lactogen, growth hormone, prolactin, corticotropin-releasing hormone (CRH), and progesterone. This evidence concerns the gene CRH and Insulin resistance.